Page 11 - நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China’s great vaccine hope, Sinopharm, sees reputation darkened amid covid spikes in countries using it Adam Taylor, Paul Schemm © Provided by The Washington Post Last year, Bahrain became one of the first countries to throw support behind China’s Sinopharm vaccine, granting it emergency use approval in December a substantial boost for Beijing’s global ambitions for the vaccine, despite doubts on the part of some scientists over lack of public safety and efficacy data. Now, the Persian Gulf country is the latest to raise doubts about the vaccine’s effectiveness. Bahraini officials told news outlets this week that it would be offering Pfizer-BioNTech doses to certain high-risk individuals who have already received two Sinopharm jabs, suggesting they no longer saw two doses of the Sinopharm vaccine as enough, in the face of a new wave of coronavirus infections.

District of columbiaUnited statesWorld health organizationAl qahirahUnited arab emiratesThe seychellesWaleed khalifa al maneaYanzhong huangBahrain news agencyInstitute of biological productsWashington postCouncil on foreign relationPersian gulfBeijing instituteBiological productsWall street journal